Salmeterol/fluticasone propionate combination therapy 50/250 μ g twice daily is more effective than budesonide 800 μ g twice daily in treating moderate to severe asthma-Reference-Cited by-同舟云学术

Salmeterol/fluticasone propionate combination therapy 50/250 μ g twice daily is more effective than budesonide 800 μ g twice daily in treating moderate to severe asthma

Published:2000-07 Issue:7 Volume:94 Page:715-723
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

JENKINS C.,WOOLCOCK A.J.,SAARELAINEN P.,LUNDBÄCK B.,JAMES M.H.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference26 articles.

1. Efficacy of inhaled corticosteroids in asthma;Barnes;J Allergy Clin Immunol,1998

2. Effects of inhaled corticosterids on the consequences of asthma;Boushey;J. Allergy Clin Immunol,1998

3. Global Initiative for Asthma (GINA), Pocketguide for asthma management and prevention, National Insitutes of Health, National Heart, Lung and Blood Insitute, November 1998

4. National Institute of Health, National Heart Lung and Blood Insitute, Guidelines for the diagnosis and management of asthma, 2, July 1997

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in the effectiveness of single, dual, and triple inhaled corticosteroid therapy for reducing future risk of severe asthma exacerbation: A systematic review and network meta-analysis;Heliyon;2024-06

2. Comparing Budesonide and Fluticasone Propionate in Children with Moderate to Severe Asthma: A Pilot Randomized Controlled Trial;Iranian Journal of Allergy, Asthma and Immunology;2024-01-06

3. Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam;Journal of Asthma;2021-03-27

4. Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β2-agonists in Patients with Moderate to Severe Asthma: A Randomized, Controlled Study;Clinical Therapeutics;2016-12

5. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma;Expert Opinion on Drug Delivery;2014-11-27